AI-generated summary
The authors report a randomized trial of 71 breast cancer patients receiving hypofractionated whole-breast radiotherapy, comparing photobiomodulation plus standard skincare with placebo plus standard skincare. Severe radiation skin reactions at the end of treatment were 10% in the photobiomodulation group versus 28% in the control group, a difference that was not statistically significant (p = 0.053). The authors conclude that photobiomodulation did not clearly reduce severe skin reactions and recommend larger studies.
- Participants
- 71
- Who or what was studied
- Breast cancer patients after lumpectomy undergoing hypofractionated whole-breast irradiation
- Limits stated in the abstract
- The authors state the difference was not significant and that research in a larger patient population is recommended.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, GRADE, Photobiomodulation therapy, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.